AMRN Amarin Corp Plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMRN

Price (delayed)

$5

Market cap

$1.98B

P/E Ratio

500

Dividend/share

N/A

EPS

$0.01

Enterprise value

$1.65B

Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its ...

Highlights
AMRN's net income has soared by 134% YoY
The company's EPS has surged by 125% YoY
AMRN's quick ratio is down by 22% year-on-year and by 9% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.amarincorp.com
Peers: ABBV ALKS TEVA

Key stats

What are the main financial stats of AMRN
Market
Shares outstanding
395.3M
Market cap
$1.98B
Enterprise value
$1.65B
Valuations
Price to earnings (P/E)
500
Price to book (P/B)
3.06
Price to sales (P/S)
3.19
EV/EBIT
134.34
EV/EBITDA
113.06
EV/Sales
2.67
Earnings
Revenue
$620.41M
EBIT
$12.32M
EBITDA
$14.63M
Free cash flow
-$61.22M
Per share
EPS
$0.01
Free cash flow per share
-$0.15
Book value per share
$1.63
Revenue per share
$1.57
TBVPS
$2.58
Balance sheet
Total assets
$1.04B
Total liabilities
$399.67M
Debt
$8.88M
Equity
$645.32M
Working capital
$625.54M
Liquidity
Debt to equity
0.01
Current ratio
2.69
Quick ratio
1.88
Net debt/EBITDA
-22.01
Margins
EBITDA margin
2.4%
Gross margin
79.3%
Net margin
0.7%
Operating margin
1.2%
Efficiency
Return on assets
0.4%
Return on equity
0.7%
Return on invested capital
3.1%
Return on capital employed
1.8%
Return on sales
2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMRN stock price

How has the Amarin stock price performed over time
Intraday
-0.2%
1 week
-3.1%
1 month
-5.48%
1 year
-0.4%
YTD
2.25%
QTD
-1.96%

Financial performance

How have Amarin's revenue and profit performed over time
Revenue
$620.41M
Gross profit
$492.09M
Operating income
$7.66M
Net income
$4.32M
Gross margin
79.3%
Net margin
0.7%
AMRN's operating income has soared by 152% since the previous quarter and by 141% year-on-year
AMRN's operating margin has surged by 140% since the previous quarter and by 134% year-on-year
AMRN's net income has soared by 134% YoY
AMRN's net margin has surged by 130% year-on-year

Growth

What is Amarin's growth rate over time

Valuation

What is Amarin stock price valuation
P/E
500
P/B
3.06
P/S
3.19
EV/EBIT
134.34
EV/EBITDA
113.06
EV/Sales
2.67
The company's EPS has surged by 125% YoY
The equity is up by 7% year-on-year
The P/S is 66% less than the 5-year quarterly average of 9.5
The revenue is up by 14% year-on-year and by 3.2% since the previous quarter

Efficiency

How efficient is Amarin business performance
The ROIC has soared by 160% YoY and by 63% QoQ
AMRN's ROE has soared by 133% YoY
Amarin's ROA has soared by 129% YoY
The company's return on sales has surged by 54% QoQ

Dividends

What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRN.

Financial health

How did Amarin financials performed over time
AMRN's total assets is 161% greater than its total liabilities
AMRN's total liabilities is up by 28% year-on-year and by 12% since the previous quarter
AMRN's quick ratio is down by 22% year-on-year and by 9% since the previous quarter
AMRN's debt is 99% smaller than its equity
Amarin's debt to equity has plunged by 80% YoY
AMRN's debt has dropped by 72% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.